Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors

Tyrosine kinase inhibitors Diarrhea Treatment Social sciences (General) H1-99 0301 basic medicine Q1-390 03 medical and health sciences Science (General) Mechanism Review Article
DOI: 10.1016/j.heliyon.2024.e27531 Publication Date: 2024-03-06T03:53:44Z
ABSTRACT
Tyrosine kinase inhibitors (TKIs) have become first-line drugs for cancer treatment. However, their clinical use is seriously hindered since many patients experience diarrhea after receiving TKIs. The mechanisms of TKI-associated remain unclear. Most existing therapies are symptomatic treatments based on and effects unsatisfactory. Therefore, clarification the underlying critical to develop effective anti-diarrhea drugs. This article summarizes several potential reviews current treatment progress.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (86)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....